Top Markets
Coin of the day
Tectonic Therapeutic, Inc. Tectonic Therapeutic, Inc.

Tectonic Therapeutic, Inc.

TECX
株式のランク #11670
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm... Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator aimed at fibrosis, and various other GPCR modulators. Tectonic Therapeutic, Inc. is situated in Watertown, Massachusetts.
株価
$35.63
最終同期: 2026-08-28
時価総額
$672.28M
変化(1日)
-2.92%
変化(1年)
39.50%
US
取引 Tectonic Therapeutic, Inc. (TECX)

カテゴリー

Tectonic Therapeutic, Inc.(TECX)の配当利回りの履歴
Tectonic Therapeutic, Inc.(銘柄コード: TECX)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Tectonic Therapeutic, Inc.(TECX)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)